ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

NCI-Approved Clinical Trials Listed For January

January 28, 2005

CCRAC Shoots Down Two Projects, Approves Others

December 15, 1978

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994